SFX by Ex Libris Inc.

Title:	Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease
Source:	Human Molecular Genetics [0964-6906] Wang, F yr:2013

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Buchheit, T. "Epigenetics and the Transition from Acute to Chronic Pain." Pain medicine 13.11 (2012): 1474-1490.
description	2.	Gidalevitz, T. "Progressive Disruption of Cellular Protein Folding in Models of Polyglutamine Diseases." Science 311.5766 (2006): 1471-1474.
description	3.	Svenningsson, P. "DARPP-32: an integrator of neurotransmission." Annual review of pharmacology and toxicology 44.1 (2004): 269-96.
description	4.	Sun, Z. "High-Resolution Enzymatic Mapping of Genomic 5-Hydroxymethylcytosine in Mouse Embryonic Stem Cells." Cell Reports 3.2 (2013): 567-576.
description	5.	Lim, S. "D-β-Hydroxybutyrate Is Protective in Mouse Models of Huntington's Disease." PLoS ONE 6.9 (2011).
description	6.	Bates, Gillian P P. "Biomedicine - One misfolded protein allows others to sneak by." Science 311.5766 (2006): 1385-1386.
description	7.	Denk, F. "Chronic pain: emerging evidence for the involvement of epigenetics." Neuron 73.3 (2012): 435-444.
description	8.	Kyranou, M. "The transition from acute to chronic pain: might intensive care unit patients be at risk?" Annals of Intensive Care 2.1 (2012): 36-36.
description	9.	Balch, William E E. "Adapting proteostasis for disease intervention." Science 319.5865 (2008): 916-9.
description	10.	Song, C. "Genome-wide Profiling of 5-Formylcytosine Reveals Its Roles in Epigenetic Priming." Cell 153.3 (2013): 678-691.
description	11.	Pastor, W. "The GLIB technique for genome-wide mapping of 5-hydroxymethylcytosine." Nature protocols 7.10 (2012): 1909-1917.
description	12.	Chen, K. "BORIS, Brother of the Regulator of Imprinted Sites, Is Aberrantly Expressed in Hepatocellular Carcinoma." Genetic testing and molecular biomarkers (2012): 160-165.
description	13.	Chen, Chun-Chang C. "The Mammalian de novo DNA Methyltransferases Dnmt3a and Dnmt3b Are Also DNA 5-Hydroxymethyl Cytosine Dehydroxymethylases." Journal of biological chemistry 287.40 (2012): 33116-33121.
description	14.	He, F. "Epigenetics in Nucleotide Repeat Expansion Disorders." Seminars in neurology 31.5 (2011): 470-483.
description	15.	Mielcarek, M. "SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6/2 mouse model of Huntington's disease." PLoS ONE 6.11 (2011).
description	16.	Granton, Sandrine M. "Targeting epigenetic mechanisms for pain relief." Current opinion in pharmacology 12.1 (2011): 35-41.
description	17.	Sailasuta, N. "Minimally invasive biomarker confirms glial activation present in Alzheimer's disease: a preliminary study." Neuropsychiatric Disease and Treatment 7 (2011): 495-499.
description	18.	Voscopoulos C, C. "When does acute pain become chronic?" British Journal of Anaesthesia 105 Suppl 1.suppl 1 (2010): 69-85.
description	19.	SAINT-CYR, Jean A. "Frontal-striatal circuit functions: Context, sequence, and consequence." Journal of the International Neuropsychological Society 9.1 (2003): 103-127.
description	20.	Kelley, Ann E E. "Memory and Addiction Shared Neural Circuitry and Molecular Mechanisms." Neuron 44.1 (2004): 161-179.